Orders from 120 EUR Free delivery from 250 EUR Ready for pickup dead drop: collect in 5 min Free parcel delivery from 250 EUR

Substances · Phenethylamine derivatives

IPPH (Isopropylphenidate)

C16H23NO2 CAS 93148-46-0 Analytical reference material — not for human consumption
Preferred name
IPPH (Isopropylphenidate)
IUPAC name
propan-2-yl 2-phenyl-2-piperidin-2-ylacetate
Parent CAS number (reference)
93148-46-0
Molecular formula
C16H23NO2
Molecular weight
261.36 g/mol
InChIKey
AZVPADMEIMLODT-UHFFFAOYSA-N
PubChem
CID 68314762
Source
PubChem
Verified synonyms & catalog abbreviations
Isopropylphenidate IPPH IPH IPPD

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

IPPH (Isopropylphenidate)

Stimulant (dopamine/norepinephrine reuptake inhibitor) Phenidate (isopropyl ester)
Verified PubChem & CAS Identity C16H23NO2 · CAS 93148-46-0 · CID 68314762
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 261.36 g/mol
Peer-Reviewed & Agency Citations 3 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

IPPH is the isopropyl ester analogue of methylphenidate and a dopamine/norepinephrine reuptake inhibitor. The bulkier ester is associated, in anecdotal comparison and in the lower intensity of the PsychonautWiki common band relative to its milligram size, with a smoother, less jittery stimulant than 4F-MPH or racemic methylphenidate. It does not release serotonin and it is not an entactogen. The reference IUPAC is the non-stereospecific name propan-2-yl 2-phenyl-2-piperidin-2-ylacetate.

Biotransformation & Active Metabolites

Ester hydrolysis yields the corresponding phenylpiperidineacetic acid, analogous to ritalinic acid, which is not the active stimulant. IPPH is not a prodrug of 4F-MPH. CAS 93148-46-0 is this isopropyl ester, not methylphenidate and not 4F-MPH (CAS 1354631-33-6).

Temporal Pharmacokinetics

Milder functional stimulant. Wakefulness and focus with less peripheral jitter than 4F-MPH, still a real NDRI with a crash and insomnia if pushed.

  1. Onset 10–30 minutes
  2. Peak Window 1.5–2.5 hours
  3. Total Window 3.5–6 hours
  4. Residual / Half-Life PsychonautWiki's summary sheet does not list a separate after-effect interval. Residual stimulation commonly fades across the offset, but a strong amount still disrupts sleep. Human half-life is not established.

Threshold 2 mg, light 5–15 mg, common 15–25 mg, strong 25–45 mg, heavy above 45 mg. The strong band is wide compared with 4F-MPH, where heavy already begins at 20 mg. That difference is why the two powders cannot share a scoop. Total duration is shorter than 4F-MPH (about 3.5–6 hours).

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
2 mg
Cognitive & Sensory

A faint increase in alertness.

Somatic & Autonomic

Minimal pulse change.

Light
5–15 mg
Cognitive & Sensory

Gentle focus and wakefulness without much mood elevation.

Somatic & Autonomic

Mild appetite loss and dry mouth.

Common Reference
15–25 mg
Cognitive & Sensory

Clear functional stimulation and sociable energy with less edge than the same person's 4F-MPH experience.

Somatic & Autonomic

Increased heart rate, appetite suppression, and light bruxism.

Strong
25–45 mg
Cognitive & Sensory

Forced wakefulness, anxiety, and scattered attention. The wide strong band is not a license to sit at the top of it.

Somatic & Autonomic

Tachycardia, vasoconstriction, sweating, and a sharper crash.

Heavy / Toxic Zone
45 mg+
Cognitive & Sensory

Agitation and compulsive repeated exposure. This is still far below a casual 'extra' if someone is thinking in 4-FA milligrams, and far above a 4F-MPH dose.

Somatic & Autonomic

Hypertensive strain, tremor, severe insomnia, and seizure risk with tramadol or an MAOI.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

25x-NBOMe and 25x-NBOH

Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.

Tramadol and DXM

Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.

Elevated Hazard — Avoid

Other stimulants, cocaine, and high-dose caffeine

Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.

Alcohol, opioids, and benzodiazepines

The stimulant hides sedation. When it drops, the depressant remains.

Caution / Receptor Attenuation

4F-MPH or methylphenidate

Additive NDRI effect. 10 mg of 4F-MPH is already a common dose of that drug and is not a small add-on.

Cannabis

Can turn a mild functional stimulant into an anxious one on the offset.

Structural Isomer & Sibling Comparison

IPPH is the smoother isopropyl phenidate: common 15–25 mg oral, about 3.5–6 hours, heavy above 45 mg. 4F-MPH is fluorinated methylphenidate, common only 10–15 mg, heavy above 20 mg, with a much longer residual tail. Methylphenidate is the methyl ester and is not dosed from this chart. Neither is 2-FMA, which is a releaser rather than an uptake inhibitor and lasts 7–9 hours.

Physicochemical Stability & Storage

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

NDRI tolerance and cross-tolerance with methylphenidate, 4F-MPH, and amphetamines. PsychonautWiki's class note is a half-reduction in about 3–7 days and a baseline approach in 1–2 weeks. Psychological dependence shows up as needing the afternoon dose to feel normal. The crash is fatigue and low motivation, not a seizure withdrawal. The wide strong band (25–45 mg) is where repeated daily use quietly settles.

Comprehensive Analytical & Toxicological Monograph

IPPH (propan-2-yl 2-phenyl-2-piperidin-2-ylacetate; isopropylphenidate; CAS 93148-46-0, PubChem CID 68314762) is the isopropyl ester analogue of methylphenidate supplied as pure powder or crystals (C16H23NO2, 261.36 g/mol). It is a dopamine/norepinephrine reuptake inhibitor with a smoother, shorter profile than 4F-MPH. PsychonautWiki oral bands are threshold 2 mg, light 5–15 mg, common 15–25 mg, strong 25–45 mg, and heavy above 45 mg, over about 3.5–6 hours. Onset is 10–30 minutes. It is not 4F-MPH, whose heavy line is already 20 mg, and it is not an entactogen. Do not combine with MAOIs, tramadol, other stimulants, or 25x-NBOMe.

Chemical Architecture & Structural Profile

IPPH (Isopropylphenidate) (propan-2-yl 2-phenyl-2-piperidin-2-ylacetate) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C16H23NO2 and a molar mass of 261.36 g/mol. The parent molecule is indexed under CAS registry number 93148-46-0 and in the NCBI PubChem database as CID 68314762 (Standard InChIKey: AZVPADMEIMLODT-UHFFFAOYSA-N).

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), IPPH (Isopropylphenidate) is indexed within the Substituted phenidates structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations

Unsafe combinations (elevated hazard)

Uncertain combinations (caution advised)